• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复杂底物与易得卤化试剂的后期卤化反应

Late-Stage Halogenation of Complex Substrates with Readily Available Halogenating Reagents.

作者信息

Wang Weijin, Song Song, Jiao Ning

机构信息

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Xue Yuan Road 38, Beijing 100191, China.

State Key Laboratory of Organometallic Chemistry, Chinese Academy of Sciences. Shanghai 200032, China.

出版信息

Acc Chem Res. 2024 Nov 5;57(21):3161-3181. doi: 10.1021/acs.accounts.4c00501. Epub 2024 Sep 20.

DOI:10.1021/acs.accounts.4c00501
PMID:39303309
Abstract

ConspectusLate-stage halogenation, targeting specific positions in complex substrates, has gained significant attention due to its potential for diversifying and functionalizing complex molecules such as natural products and pharmaceutical intermediates. Utilizing readily available halogenating reagents, such as hydrogen halides (HX), N-halosuccinimides (NXS), and dichloroethane (DCE) reagents for late-stage halogenation shows great promise for expanding the toolbox of synthetic chemists. However, the reactivity of haleniums (X, X = Cl, Br, I) can be significantly hindered by the presence of various functional groups such as hydroxyl, amine, amide, or carboxylic acid groups. The developed methods of late-stage halogenation often rely on specialized activating reagents and conditions. Recently, our group (among others) has put great efforts into addressing these challenges and unlocking the potential of these readily available HX, NXS, and DCE reagents in complex molecule halogenation. Developing new methodologies, catalyst systems, and reaction conditions further enhanced their utility, enabling the efficient and selective halogenation of intricate substrates.With the long-term goal of achieving selective halogenation of complex molecules, we summarize herein three complementary research topics in our group: (1) Efficient oxidative halogenations: Taking inspiration from naturally occurring enzyme-catalyzed oxidative halogenation reactions, we focused on developing cost-effective oxidative halogenation reactions. We found the combination of dimethyl sulfoxide (DMSO) and HX (X = Cl, Br, I) efficient for the oxidative halogenation of aromatic compounds and alkenes. Additionally, we developed electrochemical oxidative halogenation using DCE as a practical chlorinating reagent for chlorination of (hetero)arenes. (2) Halenium reagent activation: Direct electrophilic halogenation using halenium reagents is a reliable method for obtaining organohalides. However, compared to highly reactive reagents, the common and readily available NXS and dihalodimethylhydantoin (DXDMH) demonstrate relatively lower reactivity. Therefore, we focused on developing oxygen-centered Lewis base catalysts such as DMSO, 2,2,6,6-tetramethylpiperidin-1-oxyl (TEMPO) and nitromethane to activate NXS or DXDMH, enabling selective halogenation of bioactive substrates. (3) Halogenation of inert substrates: Some substrates, such as electron-poor arenes and pyridines, are inert toward electrophilic functionalization reactions. We devised several strategies to enhance the reactivity of these molecules. These strategies, characterized by mild reaction conditions, the ready availability and stability of catalysts and reagents, and excellent tolerance for various functional groups, have emerged as versatile protocols for the late-stage aromatic halogenation of drugs, natural products, and peptides. By harnessing the versatility and selectivity of these catalysts and methodologies, synthetic chemists can unlock new possibilities in the synthesis of halogenated compounds, paving the way for the development of novel functional materials and biologically active molecules.

摘要

综述

晚期卤化反应,即针对复杂底物中的特定位置进行卤化,因其能够使天然产物和药物中间体等复杂分子多样化并引入官能团的潜力而备受关注。利用易于获得的卤化试剂,如卤化氢(HX)、N-卤代琥珀酰亚胺(NXS)和二氯乙烷(DCE)试剂进行晚期卤化反应,为扩展合成化学家的工具库带来了巨大希望。然而,卤鎓离子(X,X = Cl、Br、I)的反应活性会受到各种官能团(如羟基、胺基、酰胺基或羧基)的显著阻碍。已开发的晚期卤化方法通常依赖于专门的活化试剂和条件。最近,我们小组(以及其他一些小组)付出了巨大努力来应对这些挑战,并挖掘这些易于获得的HX、NXS和DCE试剂在复杂分子卤化中的潜力。开发新的方法、催化剂体系和反应条件进一步提高了它们的实用性,实现了对复杂底物的高效和选择性卤化。

为了实现复杂分子的选择性卤化这一长期目标,我们在此总结了我们小组的三个互补研究主题:(1)高效氧化卤化反应:从天然存在的酶催化氧化卤化反应中获得灵感,我们专注于开发具有成本效益的氧化卤化反应。我们发现二甲基亚砜(DMSO)和HX(X = Cl、Br、I)的组合对于芳香族化合物和烯烃的氧化卤化反应是有效的。此外,我们开发了以DCE作为实用氯化试剂的电化学氧化卤化反应,用于(杂)芳烃的氯化。(2)卤鎓试剂活化:使用卤鎓试剂进行直接亲电卤化是获得有机卤化物的可靠方法。然而,与高活性试剂相比,常见且易于获得的NXS和二卤代二甲基乙内酰脲(DXDMH)表现出相对较低的反应活性。因此,我们专注于开发以氧为中心的路易斯碱催化剂,如DMSO、2,2,6,6-四甲基哌啶-1-氧基(TEMPO)和硝基甲烷,以活化NXS或DXDMH,实现对生物活性底物的选择性卤化。(3)惰性底物的卤化:一些底物,如缺电子芳烃和吡啶,对亲电官能化反应呈惰性。我们设计了几种策略来提高这些分子的反应活性。这些策略具有反应条件温和、催化剂和试剂易于获得且稳定以及对各种官能团具有出色耐受性的特点,已成为药物、天然产物和肽的晚期芳香卤化的通用方案。通过利用这些催化剂和方法的多功能性和选择性,合成化学家可以挖掘卤化化合物合成中的新可能性,为新型功能材料和生物活性分子的开发铺平道路。

相似文献

1
Late-Stage Halogenation of Complex Substrates with Readily Available Halogenating Reagents.复杂底物与易得卤化试剂的后期卤化反应
Acc Chem Res. 2024 Nov 5;57(21):3161-3181. doi: 10.1021/acs.accounts.4c00501. Epub 2024 Sep 20.
2
Thianthrene/TfOH-catalyzed electrophilic halogenations using -halosuccinimides as the halogen source.噻蒽/三氟甲磺酸催化的亲电卤化反应,使用α-卤代琥珀酰亚胺作为卤素源。
Chem Sci. 2024 Jul 22;15(32):13058-13067. doi: 10.1039/d4sc04461d. eCollection 2024 Aug 14.
3
Oxoammonium salts are catalysing efficient and selective halogenation of olefins, alkynes and aromatics.氧鎓铵盐可催化烯烃、炔烃和芳烃进行高效且选择性的卤化反应。
Nat Commun. 2021 Jun 23;12(1):3873. doi: 10.1038/s41467-021-24174-w.
4
Efficient and Practical Oxidative Bromination and Iodination of Arenes and Heteroarenes with DMSO and Hydrogen Halide: A Mild Protocol for Late-Stage Functionalization.DMSO 和卤化氢促进的高效实用的芳基和杂芳基的氧化溴化和碘化:一种温和的晚期功能化方法。
Org Lett. 2015 Jun 19;17(12):2886-9. doi: 10.1021/acs.orglett.5b00932. Epub 2015 May 26.
5
Late-Stage Halogenation of Peptides, Drugs and (Hetero)aromatic Compounds with a Nucleophilic Hydrazide Catalyst.使用亲核酰肼催化剂对肽、药物和(杂)芳族化合物进行后期卤化反应。
Angew Chem Int Ed Engl. 2023 Dec 18;62(51):e202312597. doi: 10.1002/anie.202312597. Epub 2023 Nov 20.
6
Identifying and Engineering Flavin Dependent Halogenases for Selective Biocatalysis.鉴定和工程化黄素依赖型卤化酶用于选择性生物催化。
Acc Chem Res. 2024 Aug 6;57(15):2067-2079. doi: 10.1021/acs.accounts.4c00172. Epub 2024 Jul 22.
7
Upgrading Cross-Coupling Reactions for Biaryl Syntheses.用于联芳基合成的交叉偶联反应升级
Acc Chem Res. 2019 Jan 15;52(1):161-169. doi: 10.1021/acs.accounts.8b00408. Epub 2018 Oct 30.
8
Complementary Site-Selective Halogenation of Nitrogen-Containing (Hetero)Aromatics with Superacids.超酸促进含氮(杂)芳烃的互补位点选择性卤化反应。
Chemistry. 2020 Aug 17;26(46):10411-10416. doi: 10.1002/chem.202000902. Epub 2020 Jul 24.
9
Shelf-stable electrophilic reagents for trifluoromethylthiolation.稳定货架的亲电子三氟甲硫基化试剂。
Acc Chem Res. 2015 May 19;48(5):1227-36. doi: 10.1021/acs.accounts.5b00047. Epub 2015 May 7.
10
Decarbonylative Cross-Couplings: Nickel Catalyzed Functional Group Interconversion Strategies for the Construction of Complex Organic Molecules.脱羰交叉偶联反应:镍催化构建复杂有机分子的官能团相互转化策略
Acc Chem Res. 2018 May 15;51(5):1185-1195. doi: 10.1021/acs.accounts.8b00023. Epub 2018 Apr 13.

引用本文的文献

1
Tracing the stepwise Darwinian evolution of a plant halogenase.追踪植物卤化酶的逐步达尔文进化过程。
Sci Adv. 2025 Aug 15;11(33):eadv6898. doi: 10.1126/sciadv.adv6898. Epub 2025 Aug 13.
2
Ring-Opening Chlorination and Bromination of Pyrazolopyridines and Isoxazoles.吡唑并吡啶和异恶唑的开环氯化和溴化反应
Chemistry. 2025 Jul 22;31(41):e202501589. doi: 10.1002/chem.202501589. Epub 2025 Jul 4.
3
Enantioconvergent Cobalt-Catalyzed Hydroalkylation for the Construction of Fluoro, Chloro, and Trifluoromethyl Stereogenic Centers.
对映汇聚式钴催化氢烷基化反应构建氟、氯和三氟甲基手性中心
Angew Chem Int Ed Engl. 2025 Aug 4;64(32):e202508637. doi: 10.1002/anie.202508637. Epub 2025 Jun 18.
4
Recent Advances in Augmenting the Therapeutic Efficacy of Peptide-Drug Conjugates.增强肽-药物偶联物治疗效果的最新进展
J Med Chem. 2025 May 8;68(9):9037-9056. doi: 10.1021/acs.jmedchem.5c00007. Epub 2025 Apr 23.